english.prescrire.org > Spotlight > 100 most recent > Fexinidazole (Fexinidazole Winthrop°) in sleeping sickness caused by Trypanosoma brucei rhodesiense

Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

Fexinidazole (Fexinidazole Winthrop°) in sleeping sickness caused by Trypanosoma brucei rhodesiense

 Marketing Authorisations  In 2018, the European Medicines Agency (EMA) evaluated the nitroimidazole antiparasitic drug fexinidazole in the treatment of trypanosomiasis due to T. brucei gambiense. In this situation, the drug represented a major therapeutic advance, with high efficacy at both stages of the disease. More recently, the EMA evaluated fexinidazole in the treatment of human African trypanosomiasis due to T. brucei rhodesiense.
Full article available for download by subscribers

 ©Prescrire 1 April 2025

Source: "Fexinidazole (Fexinidazole Winthrop°) in sleeping sickness caused by Trypanosoma brucei rhodesiense" Prescrire Int 2025; 34 (269): 94-95. Subscribers only.

Filet

Enjoy full access to Prescrire International, and support independent information

 
Share
Share on Facebook  
 
 
See also:

"Fexinidazole - Fexinidazole
Winthrop°. Sleeping sickness
caused by Trypanosoma brucei
gambiense: effective and more
convenient than injectable
treatments"
Prescrire Int 2020;
29 (221): 290-291.
Subscribers only